Evidence map›Paper›PMID 39873270›Full record

ArticleNucleic acids research2025

Simulation of adaptive immune receptors and repertoires with complex immune information to guide the development and benchmarking of AIRR machine learning.

Maria Chernigovskaya, Milena Pavlović, Chakravarthi Kanduri, Sofie Gielis, Philippe A Robert, Lonneke Scheffer, Andrei Slabodkin, Ingrid Hobæk Haff, Pieter Meysman, Gur Yaari and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Explore antibody repertoire in the era of AI.Acta biochimica et biophysica Sinica · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria ChernigovskayaDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, 0372, Norway.ORCID 0000-0002-1507-4171
Milena PavlovićDepartment of Informatics, University of Oslo, Oslo, 0373, Norway.ORCID 0000-0002-2484-3868
Chakravarthi KanduriDepartment of Informatics, University of Oslo, Oslo, 0373, Norway.ORCID 0000-0002-4783-9060
Sofie GielisDepartment of Mathematics and Computer Science, University of Antwerp, Antwerp, 2020, Belgium.ORCID 0000-0001-7678-281X
Philippe A RobertDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, 0372, Norway.ORCID 0000-0003-1345-5015
Lonneke SchefferDepartment of Informatics, University of Oslo, Oslo, 0373, Norway.ORCID 0000-0001-8900-075X
Andrei SlabodkinDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, 0372, Norway.ORCID 0000-0002-9320-1666
Ingrid Hobæk HaffDepartment of Mathematics, University of Oslo, Oslo, 0851, Norway.
Pieter MeysmanDepartment of Mathematics and Computer Science, University of Antwerp, Antwerp, 2020, Belgium.ORCID 0000-0001-5903-633X
Gur YaariFaculty of Engineering, Bar-Ilan University, Ramat Gan, 5290002, Israel.ORCID 0000-0001-9311-9884
Geir Kjetil SandveDepartment of Informatics, University of Oslo, Oslo, 0373, Norway.ORCID 0000-0002-4959-1409
Victor GreiffDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, 0372, Norway.ORCID 0000-0003-2622-5032

Funding

EU Horizon 2020 iReceptorplus 825 821European Union's Horizon 2020GreiffLabInnovative Medicines Initiative 101 007 799Norwegian Cancer Society 215817Research Council of Norway 300 740Research Council of Norway 311 341Research Foundation Flanders 1S48819NSandveLabStiftelsen Kristian Gerhard JebsenThe Leona M. and Harry B. Helmsley Charitable Trust 2019PG-T1D011UiO:LifeScience Convergence Environment ImmunolingoUiO:LifeScience Convergence Environment RealArtUiO World-Leading Research CommunityUniversity of Oslo
6 · The paper itself

Abstract

Machine learning (ML) has shown great potential in the adaptive immune receptor repertoire (AIRR) field. However, there is a lack of large-scale ground-truth experimental AIRR data suitable for AIRR-ML-based disease diagnostics and therapeutics discovery. Simulated ground-truth AIRR data are required to complement the development and benchmarking of robust and interpretable AIRR-ML methods where experimental data is currently inaccessible or insufficient. The challenge for simulated data to be useful is incorporating key features observed in experimental repertoires. These features, such as antigen or disease-associated immune information, cause AIRR-ML problems to be challenging. Here, we introduce LIgO, a software suite, which simulates AIRR data for the development and benchmarking of AIRR-ML methods. LIgO incorporates different types of immune information both on the receptor and the repertoire level and preserves native-like generation probability distribution. Additionally, LIgO assists users in determining the computational feasibility of their simulations. We show two examples where LIgO supports the development and validation of AIRR-ML methods: (i) how individuals carrying out-of-distribution immune information impacts receptor-level prediction performance and (ii) how immune information co-occurring in the same AIRs impacts the performance of conventional receptor-level encoding and repertoire-level classification approaches. LIgO guides the advancement and assessment of interpretable AIRR-ML methods.

Indexed as

Adaptive ImmunityMachine LearningReceptors, ImmunologicSoftwareBenchmarkingComputer SimulationHumansReceptors, Immunologic

Identifiers

PMID39873270
PMCPMC11773363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.